Skip to main content

Table 2 Clinicopathological characteristics of negative PLN metastasis in stage IB1-IIA2 cervical cancer patients with or without para-aortic lymphadenectomy

From: Comparison of survival outcomes with or without Para-aortic lymphadenectomy in surgical patients with stage IB1-IIA2 cervical cancer in China from 2004 to 2016

Variables

Unmatched

Matched

PALN unresected

(n = 6947,%)

PALN

Resected

(n = 237,%)

P-value

PALN unresected

(n = 948,%)

PALN

Resected

(n = 237,%)

P-value

Age (years)

48.30 ± 9.773

47.27 ± 9.262

0.108

47.85 ± 9.597

47.27 ± 9.262

0.404

FIGO stage

  

0.59

  

0.749

 IB1

4192 (60.3%)

148 (62.4%)

 

583 (61.5%)

148 (62.4%)

 

 IB2

652 (9.4%)

27 (11.4%)

 

129 (13.6%)

27 (11.4%)

 

 IIA1

1491 (21.5%)

48 (20.3%)

 

176 (18.6%)

48 (20.3%)

 

 IIA2

399 (5.7%)

9 (3.8%)

 

48 (5.1%)

9 (3.8%)

 

 IB

111 (1.6%)

2 (0.8%)

 

4 (0.4%)

2 (0.8%)

 

 IIA

103 (1.5%)

3 (1.3%)

 

8 (0.8%)

3 (1.3%)

 

Tumour size

  

0.7

  

0.304

  ≤ 4 cm

5683 (81.8%)

196 (82.7%)

 

759 (80.1%)

196 (82.7%)

 

  > 4 cm

1051 (15.1%)

36 (15.2%)

 

177 (18.7%)

36 (15.2%)

 

 Unknown

213 (3.1%)

5 (2.1%)

 

12 (1.3%)

5 (2.1%)

 

Histological type

  

< 0.001

  

0.798

 SCC

6255 (90.0%)

189 (79.7%)

 

761 (80.3%)

189 (79.7%)

 

 AC

539 (7.8%)

39 (16.5%)

 

159 (16.8%)

39 (16.5%)

 

 SAC

153 (2.2%)

9 (3.8%)

 

28 (3.0%)

9 (3.8%)

 

Parametrial

  

0.051

  

0.059

 Negative

6886 (99.1%)

232 (97.9%)

 

941 (99.3%)

232 (97.9%)

 

 Positive

61 (0.9%)

5 (2.1%)

 

7 (0.7%)

5 (2.1%)

 

Vaginal margin

  

0.142

  

0.668

 Negative

6808 (98.0%)

229 (96.6%)

 

921 (97.2%)

229 (96.6%)

 

 Positive

139 (2.0%)

8 (3.4%)

 

27 (2.8%)

8 (3.4%)

 

LVSI

  

0.603

  

0.836

 Negative

6003 (86.4%)

202 (85.2%)

 

813 (85.8%)

202 (85.2%)

 

 Positive

944 (13.6%)

35 (14.8%)

 

135 (14.2%)

35 (14.8%)

 

Cervical invasion

  

0.601

  

0.525

  ≤ 1/2

3067 (44.1%)

99 (41.8%)

 

431 (45.5%)

99 (41.8%)

 

  > 1/2

3381 (48.7%)

123 (51.9%)

 

453 (47.8%)

123 (51.9%)

 

 Unknown

499 (7.2%)

15 (6.3%)

 

64 (6.8%)

15 (6.3%)

 

POAT

  

0.354

  

0.914

 Standard

3486 (50.2%)

106 (44.7%)

 

422 (44.5%)

106 (44.7%)

 

 Inadequate

371 (5.3%)

16 (6.8%)

 

56 (5.9%)

16 (6.8%)

 

 Over

2927 (42.1%)

110 (46.4%)

 

444 (46.8%)

110 (46.4%)

 

 Unknown

163 (2.3%)

5 (2.1%)

 

26 (2.7%)

5 (2.1%)

 
  1. PALN para-aortic lymph node, PLN pelvic lymph node, FIGO International Federation of Gynaecology and Obstetrics, SCC squamous cell carcinoma, AC adenocarcinoma, SAC adenosquamous carcinoma, LVSI lymphatic vessel space, POAT postoperative adjuvant treatment